Anastrozole
Also known as: Arimidex
Aromatase Inhibitor | Estrogen Management
Overview
Anastrozole is a potent, selective, nonsteroidal aromatase inhibitor that blocks the enzyme aromatase (CYP19A1), preventing the conversion of androgens (testosterone and androstenedione) into estrogens (estradiol and estrone). It is FDA-approved under the brand name Arimidex for the treatment of hormone receptor-positive breast cancer in postmenopausal women. In the bodybuilding and hormone optimization community, anastrozole is widely used as an ancillary compound during testosterone or anabolic steroid cycles to manage estrogen-related side effects such as gynecomastia, water retention, and elevated blood pressure. Unlike SERMs, which block estrogen at the receptor, anastrozole reduces circulating estrogen levels directly by inhibiting its synthesis. This distinction is clinically important: while effective at preventing estrogenic side effects, anastrozole carries the risk of suppressing estrogen too aggressively, which can impair joint health, bone density, cardiovascular markers, and mood. A common starting-point rule of thumb: weekly testosterone dose (mg) divided by 500 equals mg of anastrozole per week. For example, 500 mg of testosterone per week would correspond to roughly 1 mg of anastrozole per week, split across injection days. This is only a rough guideline -- individual aromatization rates vary widely, and dosing should always be refined based on bloodwork.
Key benefits
- Potent reduction of circulating estradiol levels (70-80% at standard dose)
- Prevents gynecomastia during testosterone or anabolic steroid cycles
- Reduces estrogen-driven water retention and bloating
- Helps control estrogen-related blood pressure elevation
- Oral dosing with long half-life allows flexible scheduling (EOD or E3D)
- Reversible inhibition allows estrogen recovery after discontinuation
- Well-characterized pharmacokinetics with decades of clinical data
Mechanism of action
Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain. By blocking this conversion, anastrozole reduces circulating estradiol concentrations by approximately 70-80% at the standard 1mg daily dose. In men using exogenous testosterone, aromatase activity is upregulated due to elevated substrate availability, leading to supraphysiological estradiol. Anastrozole counteracts this by limiting estrogen synthesis at the enzymatic level. The inhibition is reversible, meaning estrogen production resumes once the drug is cleared, unlike exemestane which irreversibly inactivates aromatase. Because estrogen plays essential physiological roles in men -- including bone metabolism, lipid homeostasis, neurocognition, and joint lubrication -- the goal of anastrozole use is modulation rather than elimination.
Molecular data
- Type
- Nonsteroidal aromatase inhibitor (triazole derivative)
- Half-life
- ~40-50 hours
Indications
What the research community uses this compound for, with self-reported effectiveness.
On-Cycle Estrogen Management
Medical Applications
Hormonal Optimization
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Delivery method
| Protocol | Dose | Frequency | Duration |
|---|---|---|---|
| — | 0.25mg | Every other day (EOD) or every 3 days (E3D) | — |
| — | 0.5mg | Every other day (EOD) or every 3 days (E3D) | — |
| — | 1mg | Every other day (EOD) | — |
| — | 0.125-0.25mg | Twice weekly or as needed based on bloodwork | — |
| — | 1mg | Once daily | — |
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Joint pain, stiffness, or dryness (from reduced estrogen-mediated joint lubrication)
- Hot flashes or flushing
- Fatigue and general malaise
- Mood changes (flat affect, irritability, or low mood)
- Decreased libido (when estrogen is suppressed too aggressively)
- Headache
Rare side effects
- Bone mineral density loss with chronic use (estrogen is essential for bone metabolism)
- Adverse lipid changes (reduced HDL, elevated LDL)
- Elevated liver enzymes
- Skin rash or allergic reaction
- Carpal tunnel syndrome
- Thromboembolic events (very rare)
Contraindications
- Known hypersensitivity to anastrozole or any excipients
- Premenopausal women (not indicated and potentially harmful to reproductive function)
- Pregnancy or breastfeeding (teratogenic risk)
- Severe hepatic impairment
- Pre-existing severe osteoporosis or high fracture risk
- Concurrent use with tamoxifen or estrogen-containing therapies
References
Primary literature and clinical-trial data informing this entry.